Dataset in. CSV. by Kare Chawicha Debessa (20660605)

“…Lower dropout likelihood was significantly associated with increased age (AOR = 0.93; 95% CI: 0.89–0.97; p < 0.001) and larger family size (AOR = 0.28; 95% CI: 0.17–0.50; p < 0.001).…”

Patients outcome. by Loïc Duron (6433634)

“…Mean total medical costs decreased by €814 per patient (€3672 ± 2861 vs €4486 ± 3193), although this difference did not reach statistical significance (p = 0.23).…”

Individual data. by JoEllen M. Sefton (16880253)

“…Total kcals did not differ between conditions (with/without exoskeleton; t = 0.98; p = 0.357). Kcals/min were significantly lower (1.06 kcals/min) with the exoskeleton (t = 3.94; p = 0.004). …”

Descriptive statistics. by JoEllen M. Sefton (16880253)

“…Total kcals did not differ between conditions (with/without exoskeleton; t = 0.98; p = 0.357). Kcals/min were significantly lower (1.06 kcals/min) with the exoskeleton (t = 3.94; p = 0.004). …”

Time matched metabolic cost. by JoEllen M. Sefton (16880253)

“…Total kcals did not differ between conditions (with/without exoskeleton; t = 0.98; p = 0.357). Kcals/min were significantly lower (1.06 kcals/min) with the exoskeleton (t = 3.94; p = 0.004). …”

Research design. by JoEllen M. Sefton (16880253)

“…Total kcals did not differ between conditions (with/without exoskeleton; t = 0.98; p = 0.357). Kcals/min were significantly lower (1.06 kcals/min) with the exoskeleton (t = 3.94; p = 0.004). …”

Time matched physiological strain. by JoEllen M. Sefton (16880253)

“…Total kcals did not differ between conditions (with/without exoskeleton; t = 0.98; p = 0.357). Kcals/min were significantly lower (1.06 kcals/min) with the exoskeleton (t = 3.94; p = 0.004). …”

Physiological strain. by JoEllen M. Sefton (16880253)

“…Total kcals did not differ between conditions (with/without exoskeleton; t = 0.98; p = 0.357). Kcals/min were significantly lower (1.06 kcals/min) with the exoskeleton (t = 3.94; p = 0.004). …”

Diagram of exercise intervention progression. by JoEllen M. Sefton (16880253)

“…Total kcals did not differ between conditions (with/without exoskeleton; t = 0.98; p = 0.357). Kcals/min were significantly lower (1.06 kcals/min) with the exoskeleton (t = 3.94; p = 0.004). …”

Perceived exertion. by JoEllen M. Sefton (16880253)

“…Total kcals did not differ between conditions (with/without exoskeleton; t = 0.98; p = 0.357). Kcals/min were significantly lower (1.06 kcals/min) with the exoskeleton (t = 3.94; p = 0.004). …”

Metabolic cost. by JoEllen M. Sefton (16880253)

“…Total kcals did not differ between conditions (with/without exoskeleton; t = 0.98; p = 0.357). Kcals/min were significantly lower (1.06 kcals/min) with the exoskeleton (t = 3.94; p = 0.004). …”

PERCOM, an unbiased and easily-accessible protein-centric analysis workflow. by Brian Foo (19273132)

Riboflavin inhibits growth and reduces virulence of <i>Cryptococcus neoformans in vitro</i> by membrane disruption and excessive accumulation of reactive oxygen species and exhibit... by Jian Huang (7250)

“…Finally, in mouse models of intranasal and intravenous infection, RF treatment significantly reduced the fungal burden in multiple organs, reduced lung and brain damage, and decreased the levels of plasma interferon (IFN)-γ, tumor necrosis factor (TNF)-α, and interleukin (IL)-4 in the early stage of infection. …”

Data Sheet 1_Evaluating the therapeutic potential of BSA-reduced mussel-derived selenium nanoparticles to mitigate copper sulfate-induced hepatic damage and neurodegeneration in a... by Suganiya Umapathy (21383339)

“…Stabilized selenium nanoparticles reduced for 30 minutes (25 μg/ml) showed significant in vitro reactive oxygen species scavenging activity and improved in vivo antioxidant enzyme levels by decreasing lipid peroxidation and nitric oxide levels. …”

Estimating RSA Variability in Each SCP Condition. by Hikari Otsuka (18605246)

Image 1_Ivarmacitinib reduces the need for adding/escalating medications in moderate-to-severe rheumatoid arthritis patients: a post hoc analysis from a phase III trial.tif by Huaxiang Liu (322464)

“…</p>Conclusion<p>Ivarmacitinib significantly reduces the need for adding/escalating medications compared to placebo, thereby potentially decreasing treatment burden. …”

Regional work heterogeneity in LBBB differs between responders and non-responders, but LV stroke work, myocardial work, and efficiency do not. by Amanda Craine (19832365)

Critical Role of Transcription Factor CtSR in Mediating Ergosterol Biosynthesis and DMI Fungicides Sensitivity in Colletotrichum truncatum by Wei Sun (93580)

“…Deletion of <i>CtSR</i> rendered a naturally resistant isolate highly sensitive to DMIs, significantly reduced total ergosterol levels, decreased <i>CYP51s</i> expression compared to the wild type, and abolished DMI-induced expression of <i>CYP51s</i>. …”

Critical Role of Transcription Factor CtSR in Mediating Ergosterol Biosynthesis and DMI Fungicides Sensitivity in Colletotrichum truncatum by Wei Sun (93580)

“…Deletion of <i>CtSR</i> rendered a naturally resistant isolate highly sensitive to DMIs, significantly reduced total ergosterol levels, decreased <i>CYP51s</i> expression compared to the wild type, and abolished DMI-induced expression of <i>CYP51s</i>. …”

Data Sheet 1_Efficacy of different pharmaceutical forms of Curcuma longa or curcumin in reducing oral mucositis severity and incidence in cancer patients: a systematic review and m... by Pedro de Padua G. Amatto (20981201)

“…The pooled analysis showed significant reductions in WHO scores and oral pain compared to placebo. …”